Blue Cross and Blue Shield of Illinois policies

Search Blue Cross and Blue Shield of Illinois's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

18 policies name 86817, those listing the fewest codes first. A policy that names a code may also list it as excluded.

Blue Cross and Blue Shield of Illinois policies
PolicyDetailsCodesSource
Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative NeoplasmsSUR703.032 · Commercial, Medicaid67Original policy ↗
Hematopoietic Cell Transplantation for Breast CancerSUR703.038 · Commercial, Medicaid67Original policy ↗
Hematopoietic Cell Transplantation for Chronic Myeloid LeukemiaSUR703.041 · Commercial, Medicaid67Original policy ↗
Hematopoietic Cell Transplantation for Epithelial Ovarian CancerSUR703.034 · Commercial, Medicaid67Original policy ↗
Hematopoietic Cell Transplantation for Genetic Diseases and Acquired AnemiasSUR703.033 · Commercial, Medicaid67Original policy ↗
Hematopoietic Cell Transplantation for Acute Myeloid LeukemiaSUR703.037 · Commercial, Medicaid68Original policy ↗
Hematopoietic Cell Transplantation for Central Nervous System Embryonal Tumors and EpendymomaSUR703.039 · Commercial, Medicaid68Original policy ↗
Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)SUR703.029 · Commercial, Medicaid68Original policy ↗
Hematopoietic Cell Transplantation for Miscellaneous Solid Tumors in AdultsSUR703.035 · Commercial, Medicaid68Original policy ↗
Hematopoietic Cell Transplantation for Plasma Cell Dyscrasias, Including Multiple Myeloma and POEMS SyndromeSUR703.030 · Commercial, Medicaid68Original policy ↗
Hematopoietic Cell Transplantation for Primary Systemic AmyloidosisSUR703.046 · Commercial, Medicaid68Original policy ↗
Hematopoietic Cell Transplantation for Solid Tumors of ChildhoodSUR703.044 · Effective Jun 15, 2026 · Commercial, Medicaid68Original policy ↗
Hematopoietic Cell Transplantation for Waldenstrom MacroglobulinemiaSUR703.050 · Commercial, Medicaid68Original policy ↗
Hematopoietic Cell Transplantation for Autoimmune DiseasesSUR703.036 · Effective Jun 15, 2026 · Commercial, Medicaid69Original policy ↗
Hematopoietic Cell Transplantation for Hodgkin LymphomaSUR703.040 · Effective Apr 15, 2026 · Commercial, Medicaid69Original policy ↗
Hematopoietic Cell Transplantation for Acute Lymphoblastic LeukemiaSUR703.043 · Commercial, Medicaid70Original policy ↗
Hematopoietic Cell Transplantation in the Treatment of Germ Cell TumorsSUR703.045 · Commercial, Medicaid70Original policy ↗
Hematopoietic Cell Transplantation for Non-Hodgkin LymphomasSUR703.031 · Effective May 1, 2026 · Commercial, Medicaid72Original policy ↗

Back to Blue Cross and Blue Shield of Illinois

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.